Amine Benmoussa

Amine has over 15 years of experience in HealthTech investing across in North America and in Europe.

Before joining Karista, Amine was as an investor with the BDC Healthcare Fund in Canada leading or co-leading investments in early- to mid-stage healthcare companies. He also served on the boards of several high-growth firms including Circle Cardiovascular Imaging (acq. by Thoma Bravo), Clearwater Clinical (acq. by Sivantos), Clementia Pharmaceuticals (IPO and later acq. by IPSEN), Milestone Pharmaceuticals (IPO), and Swift Medical.

At Karista, Amine specializes in healthcare and Digital Health ventures and serves on the boards of RebrAIn and SamanTree. He is also actively engaged in the firm’s fundraising efforts.

Amine holds a Bachelor's in Computer Science from Concordia University and an MBA from HEC Montreal with executive training in PE & VC at Harvard Business School and Corporate Governance at the Rotman School of Management.